Literature DB >> 26934470

Defining appropriateness criteria for endoscopic sinus surgery during management of uncomplicated adult chronic rhinosinusitis: a RAND/UCLA appropriateness study.

Luke Rudmik1, Zachary M Soler2, Claire Hopkins3, Rodney J Schlosser4, Anju Peters5, Andrew A White6, Richard R Orlandi7, Wytske J Fokkens8, Richard Douglas9, Timothy L Smith10.   

Abstract

INTRODUCTION: Appropriate indications for endoscopic sinus surgery (ESS) for chronic rhinosinusitis (CRS) are currently poorly defined. The lack of clear surgical indications for ESS likely contributes to the large geographic variation in surgical rates and contributes to reduced quality of care. The objective of this study was to define appropriateness criteria for ESS during management of adult patients with uncomplicated CRS.
METHODS: The RAND/UCLA appropriateness methodology was performed. An international, multi-disciplinary panel of 10 experts in CRS was formed and completed two rounds of a modified Delphi ranking process along with a face-to-face meeting.
RESULTS: A total of 624 clinical scenarios were ranked, 312 scenarios each for CRS with and CRS without nasal polyps. For adult patients with uncomplicated CRS with nasal polyps, ESS can be appropriately offered when the CT Lund-Mackay score is ≥ 1 and there has been a minimum trial of a topical intranasal corticosteroid plus a short-course of systemic corticosteroid with a post-treatment total SNOT-22 score ≥ 20. For adult patients with uncomplicated CRS without nasal polyps, ESS can be appropriately offered when the CT Lund-Mackay score is ≥ 1 and there has been a minimum trial of a topical intranasal corticosteroid plus either a short-course of a broad spectrum/culture-directed systemic antibiotic or the use of a prolonged course of systemic low-dose anti-inflammatory antibiotic with a post-treatment total SNOT-22 score ≥ 20.
CONCLUSION: This study has developed and reported of list of appropriateness criteria to offer ESS as a treatment option during management of uncomplicated adult CRS. The extent or technique of ESS was not addressed in this study and will depend on surgeon and patient factors. Furthermore, these criteria are the minimal threshold to make ESS a treatment option and do not imply that all patients meeting these criteria require surgery. The decision to perform ESS should be made after an informed patient makes a preference-sensitive decision to proceed with surgery. Applying these appropriateness criteria for ESS may optimize patient selection, reduce the incidence of unwarranted surgery, and assist clinicians in providing high quality, patient-centered care to patients with CRS.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26934470     DOI: 10.4193/Rhino16.023

Source DB:  PubMed          Journal:  Rhinology        ISSN: 0300-0729            Impact factor:   3.681


  11 in total

1.  The treatment efficacy of nasal polyposis on olfactory functions, clinical scoring systems and inflammation markers.

Authors:  Zehra Betul Paksoy; Melih Cayonu; Cigdem Yucel; Turan Turhan
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-08-31       Impact factor: 2.503

Review 2.  Economics of Chronic Rhinosinusitis.

Authors:  Luke Rudmik
Journal:  Curr Allergy Asthma Rep       Date:  2017-04       Impact factor: 4.806

3.  Prognostic factors for polyp recurrence in chronic rhinosinusitis with nasal polyps.

Authors:  Junqin Bai; Julia H Huang; Caroline P E Price; Jacob M Schauer; Lydia A Suh; Regan Harmon; David B Conley; Kevin C Welch; Robert C Kern; Stephanie Shintani-Smith; Anju T Peters; Whitney W Stevens; Atsushi Kato; Robert P Schleimer; Bruce K Tan
Journal:  J Allergy Clin Immunol       Date:  2022-03-16       Impact factor: 14.290

4.  Appropriateness criteria predict outcomes for sinus surgery and may aid in future patient selection.

Authors:  Daniel M Beswick; Jess C Mace; Zachary M Soler; Noel F Ayoub; Luke Rudmik; Adam S DeConde; Timothy L Smith
Journal:  Laryngoscope       Date:  2018-05-14       Impact factor: 3.325

5. 

Authors:  L Klimek; S Becker; R Buhl; A M Chaker; T Huppertz; T K Hoffmann; S Dazert; T Deitmer; U Förster-Ruhrmann; H Olze; J Hagemann; S K Plontke; H Wrede; W Schlenter; H J Welkoborsky; B Wollenberg; A G Beule; C Rudack; S Strieth; R Mösges; C Bachert; T Stöver; C Matthias; A Dietz
Journal:  Laryngorhinootologie       Date:  2020-05-08       Impact factor: 1.057

Review 6.  EUFOREA consensus on biologics for CRSwNP with or without asthma.

Authors:  Wytske J Fokkens; Valerie Lund; Claus Bachert; Joaquim Mullol; Leif Bjermer; Jean Bousquet; Giorgio W Canonica; Lauren Deneyer; Martin Desrosiers; Zuzana Diamant; Joseph Han; Enrico Heffler; Claire Hopkins; Roger Jankowski; Guy Joos; Andrew Knill; Jivianne Lee; Stella E Lee; Gert Mariën; Benoit Pugin; Brent Senior; Sven F Seys; Peter W Hellings
Journal:  Allergy       Date:  2019-07-15       Impact factor: 13.146

7.  Real-life assessment of chronic rhinosinusitis patients using mobile technology: The mySinusitisCoach project by EUFOREA.

Authors:  Sven F Seys; Shana De Bont; Wytske J Fokkens; Claus Bachert; Isam Alobid; Manuel Bernal-Sprekelsen; Leif Bjermer; Ina Callebaut; Lars-Olaf Cardell; Sean Carrie; Paolo Castelnuovo; Russell Cathcart; Jannis Constantinidis; Leen Cools; Marjolein Cornet; Gregory Clement; Tony Cox; Lieve Delsupehe; Jaime Correia-de-Sousa; Lauren Deneyer; Geert De Vos; Zuzana Diamant; Maria Doulaptsi; Simon Gane; Philippe Gevaert; Claire Hopkins; Valérie Hox; Thomas Hummel; Werner Hosemann; Raf Jacobs; Mark Jorissen; Anette Kjeldsen; Basile N Landis; Winde Lemmens; Andreas Leunig; Valerie Lund; Gert Mariën; Joaquim Mullol; Metin Onerci; Susanna Palkonen; Isabel Proano; Emmanuel Prokopakis; Dermot Ryan; Herbert Riechelmann; Pernilla Sahlstrand-Johnson; Sanna Salmi-Toppila; Christine Segboer; Kato Speleman; Andreas Steinsvik; Pavol Surda; Peter-Valentin Tomazic; Olivier Vanderveken; Laura Van Gerven; Thibaut Van Zele; Jan Verfaillie; Benedicte Verhaeghe; Kathie Vierstraete; Stephan Vlaminck; Martin Wagenmann; Benoit Pugin; Peter W Hellings
Journal:  Allergy       Date:  2020-06-19       Impact factor: 13.146

Review 8.  [Dupilumab has an additional benefit in treatment of chronic rhinosinusitis with nasal polyps].

Authors:  L Klimek; A Chaker; T Deitmer; S K Plontke; B Wollenberg; J Bousquet; C Bachert
Journal:  HNO       Date:  2021-03-18       Impact factor: 1.284

9.  Radioanatomical study of the extended free nasal floor mucosal graft and its clinical applications.

Authors:  Jaime González-García; Ramón Moreno-Luna; José Palacios-García; Alfonso Del Cuvillo Bernal; Juan M Maza-Solano; Jaime Santos Pérez; Carlos D Pinheiro-Neto; Serafín Sánchez-Gómez; Jesús Ambrosiani Fernández
Journal:  Laryngoscope Investig Otolaryngol       Date:  2020-11-18

Review 10. 

Authors:  Ludger Klimek; Ulrike Förster-Ruhrmann; Achim G Beule; Adam M Chaker; Jan Hagemann; Felix Klimek; Ingrid Casper; Tilman Huppertz; Thomas K Hoffmann; Stefan Dazert; Thomas Deitmer; Heidi Olze; Sebastian Strieth; Holger Wrede; Wolfgang W Schlenter; Hans-Jürgen Welkoborsky; Barbara Wollenberg; Christoph Bergmann; Mandy Cuevas; Caroline Beutner; Moritz Gröger; Sven Becker
Journal:  Allergo J       Date:  2022-09-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.